SIMILAR PATTERNS OF AMINO ACIDS FOR 5KR1_B_017B101_2
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e43 | ALPHA-AMYLASE (Bacillusamyloliquefaciens) |
PF00128(Alpha-amylase)PF09154(DUF1939) | 4 | GLY A 106ALA A 107ASP A 108ASP A 138 | None | 0.46A | 5kr1B-1e43A:undetectable | 5kr1B-1e43A:12.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 4 | ALA A 28ASP A 29VAL A 32GLY A 48 | A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.4A)A79 A 800 (-3.6A) | 0.64A | 5kr1B-1hvcA:13.7 | 5kr1B-1hvcA:44.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32GLY A 49ILE A 50 | A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)A79 A 800 ( 4.4A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A) | 0.55A | 5kr1B-1hvcA:13.7 | 5kr1B-1hvcA:44.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32GLY A 49ILE A 50 | A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 ( 4.7A)A79 A 800 ( 4.3A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A) | 0.54A | 5kr1B-1hvcA:13.7 | 5kr1B-1hvcA:44.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1olx | 2-OXOISOVALERATEDEHYDROGENASE BETASUBUNIT (Homo sapiens) |
PF02779(Transket_pyr)PF02780(Transketolase_C) | 5 | GLY B 90ALA B 91VAL B 42GLY B 83ILE B 84 | None | 1.38A | 5kr1B-1olxB:undetectable | 5kr1B-1olxB:17.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32 | None | 0.47A | 5kr1B-1q9pA:10.0 | 5kr1B-1q9pA:93.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50 | None | 0.60A | 5kr1B-1sivA:18.0 | 5kr1B-1sivA:50.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tlg | POLYANDROCARPALECTIN (Polyandrocarpamisakiensis) |
PF00059(Lectin_C) | 4 | GLY A 56ALA A 57ASP A 58GLY A 72 | None | 0.61A | 5kr1B-1tlgA:undetectable | 5kr1B-1tlgA:17.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w8j | MYOSIN VA (Gallus gallus) |
PF00063(Myosin_head) | 5 | ALA A 173ASP A 437VAL A 161GLY A 434ILE A 433 | None | 1.50A | 5kr1B-1w8jA:undetectable | 5kr1B-1w8jA:9.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x0u | HYPOTHETICALMETHYLMALONYL-COADECARBOXYLASE ALPHASUBUNIT (Sulfurisphaeratokodaii) |
PF01039(Carboxyl_trans) | 4 | GLY A 424ALA A 425ASP A 426ILE A 354 | None | 0.52A | 5kr1B-1x0uA:undetectable | 5kr1B-1x0uA:17.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x7f | OUTER SURFACEPROTEIN (Bacillus cereus) |
PF05913(DUF871) | 4 | GLY A 92ALA A 93ASP A 94ILE A 55 | None | 0.60A | 5kr1B-1x7fA:undetectable | 5kr1B-1x7fA:12.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yw6 | SUCCINYLGLUTAMATEDESUCCINYLASE (Escherichiacoli) |
PF04952(AstE_AspA) | 4 | GLY A 180ALA A 179GLY A 242ILE A 243 | None | 0.66A | 5kr1B-1yw6A:undetectable | 5kr1B-1yw6A:15.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2di4 | CELL DIVISIONPROTEIN FTSH HOMOLOG (Aquifexaeolicus) |
PF01434(Peptidase_M41) | 4 | GLY A 492ALA A 493ASP A 496ILE A 417 | NoneNone HG A1001 (-2.3A)None | 0.67A | 5kr1B-2di4A:undetectable | 5kr1B-2di4A:16.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ewn | BIRA BIFUNCTIONALPROTEIN (Escherichiacoli) |
PF02237(BPL_C)PF03099(BPL_LplA_LipB)PF08279(HTH_11) | 5 | GLY A 186ALA A 185VAL A 169GLY A 154ILE A 153 | BTX A 501 (-3.3A)NoneNoneNoneNone | 1.46A | 5kr1B-2ewnA:undetectable | 5kr1B-2ewnA:17.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29VAL A 32GLY A 54 | LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)NoneLP1 A 201 (-3.6A) | 0.72A | 5kr1B-2fmbA:15.2 | 5kr1B-2fmbA:33.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29VAL A 32GLY A 55 | LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)NoneLP1 A 201 (-3.4A) | 0.46A | 5kr1B-2fmbA:15.2 | 5kr1B-2fmbA:33.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fw2 | TESTIS-SPECIFICCHROMODOMAIN PROTEINY 2 (Homo sapiens) |
PF00378(ECH_1) | 4 | ASN A 108GLY A 109VAL A 105GLY A 115 | None | 0.57A | 5kr1B-2fw2A:undetectable | 5kr1B-2fw2A:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gwc | GLUTAMATE CYSTEINELIGASE (Brassica juncea) |
PF04107(GCS2) | 4 | GLY A 388ALA A 389ASP A 390ILE A 270 | None | 0.53A | 5kr1B-2gwcA:undetectable | 5kr1B-2gwcA:11.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50 | AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A) | 0.40A | 5kr1B-2rkfA:20.4 | 5kr1B-2rkfA:76.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vn8 | RETICULON-4-INTERACTING PROTEIN 1 (Homo sapiens) |
PF08240(ADH_N)PF13602(ADH_zinc_N_2) | 4 | GLY A 248ALA A 249ASP A 250ASP A 251 | None | 0.61A | 5kr1B-2vn8A:undetectable | 5kr1B-2vn8A:15.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wd9 | ACYL-COENZYME ASYNTHETASE ACSM2A,MITOCHONDRIAL (Homo sapiens) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 4 | GLY A 280ALA A 281ASP A 255GLY A 247 | None | 0.62A | 5kr1B-2wd9A:undetectable | 5kr1B-2wd9A:11.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wtb | FATTY ACIDMULTIFUNCTIONALPROTEIN (ATMFP2) (Arabidopsisthaliana) |
PF00378(ECH_1)PF00725(3HCDH)PF02737(3HCDH_N) | 4 | ALA A 497VAL A 488GLY A 658ILE A 671 | None | 0.64A | 5kr1B-2wtbA:undetectable | 5kr1B-2wtbA:7.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y9e | MYOSIN-2 (Dictyosteliumdiscoideum) |
PF00063(Myosin_head)PF02736(Myosin_N) | 4 | GLY X 255ALA X 256GLY X 451ILE X 450 | None | 0.63A | 5kr1B-2y9eX:undetectable | 5kr1B-2y9eX:10.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yjt | ATP-DEPENDENT RNAHELICASE SRMB (Escherichiacoli) |
PF00271(Helicase_C) | 4 | ALA D 229ASP D 230ASP D 231ILE D 376 | None | 0.66A | 5kr1B-2yjtD:undetectable | 5kr1B-2yjtD:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yjv | REGULATOR OFRIBONUCLEASEACTIVITY A (Escherichiacoli) |
PF03737(RraA-like) | 4 | GLY A 67ASP A 64VAL A 91GLY A 134 | None | 0.57A | 5kr1B-2yjvA:undetectable | 5kr1B-2yjvA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zki | 199AA LONGHYPOTHETICAL TRPREPRESSOR BINDINGPROTEIN (Sulfurisphaeratokodaii) |
PF03358(FMN_red) | 4 | GLY A 162ALA A 163GLY A 184ILE A 187 | None | 0.59A | 5kr1B-2zkiA:undetectable | 5kr1B-2zkiA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3be7 | ZN-DEPENDENTARGININECARBOXYPEPTIDASE (unidentified) |
PF01979(Amidohydro_1) | 4 | GLY A 317ASP A 320ASP A 323ILE A 272 | GOL A 502 (-3.6A)NoneNoneNone | 0.56A | 5kr1B-3be7A:undetectable | 5kr1B-3be7A:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c8o | REGULATOR OFRIBONUCLEASEACTIVITY A (Pseudomonasaeruginosa) |
PF03737(RraA-like) | 4 | GLY A 67ASP A 64VAL A 91GLY A 134 | EDO A 177 (-4.3A)NoneNoneNone | 0.66A | 5kr1B-3c8oA:undetectable | 5kr1B-3c8oA:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3etl | DNA REPAIR ANDRECOMBINATIONPROTEIN RADA (Methanococcusmaripaludis) |
PF08423(Rad51)PF14520(HHH_5) | 4 | GLY A 165ALA A 166GLY A 83ILE A 320 | None | 0.60A | 5kr1B-3etlA:undetectable | 5kr1B-3etlA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g7r | PUTATIVETRANSCRIPTIONALREGULATOR (Streptomycescoelicolor) |
PF00440(TetR_N) | 4 | GLY A 166ALA A 167VAL A 99GLY A 186 | None | 0.67A | 5kr1B-3g7rA:undetectable | 5kr1B-3g7rA:17.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gmi | UPF0348 PROTEINMJ0951 (Methanocaldococcusjannaschii) |
PF05636(HIGH_NTase1)PF16581(HIGH_NTase1_ass) | 4 | GLY A 111ALA A 112ASP A 113GLY A 73 | None | 0.61A | 5kr1B-3gmiA:undetectable | 5kr1B-3gmiA:15.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gve | YFKN PROTEIN (Bacillussubtilis) |
PF00149(Metallophos) | 4 | GLY A 121ALA A 122ASP A 123ILE A 89 | None | 0.64A | 5kr1B-3gveA:undetectable | 5kr1B-3gveA:16.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hrx | PROBABLE ENOYL-COAHYDRATASE (Thermusthermophilus) |
PF00378(ECH_1) | 4 | ASN A 99GLY A 100VAL A 96GLY A 106 | None | 0.54A | 5kr1B-3hrxA:undetectable | 5kr1B-3hrxA:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hst | PROTEINRV2228C/MT2287 (Mycobacteriumtuberculosis) |
PF13456(RVT_3) | 5 | ALA B 132ASP B 131ASP B 128GLY B 19ILE B 40 | None | 1.24A | 5kr1B-3hstB:undetectable | 5kr1B-3hstB:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i5g | MYOSIN HEAVY CHAINISOFORM A (Doryteuthispealeii) |
PF00063(Myosin_head)PF00612(IQ)PF02736(Myosin_N) | 5 | GLY A 264ALA A 265ASP A 266GLY A 460ILE A 459 | None | 0.68A | 5kr1B-3i5gA:undetectable | 5kr1B-3i5gA:8.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ke6 | PROTEINRV1364C/MT1410 (Mycobacteriumtuberculosis) |
PF07228(SpoIIE)PF13581(HATPase_c_2) | 4 | GLY A 175ALA A 176ASP A 177GLY A 320 | None | 0.58A | 5kr1B-3ke6A:undetectable | 5kr1B-3ke6A:12.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m8y | PHOSPHOPENTOMUTASE (Bacillus cereus) |
PF01676(Metalloenzyme) | 5 | ASP A 286ASP A 13VAL A 11GLY A 16ILE A 34 | MN A 395 (-2.2A) MN A 396 (-2.0A)NoneNoneNone | 1.36A | 5kr1B-3m8yA:undetectable | 5kr1B-3m8yA:14.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mmp | ELONGATION FACTOR TU2, ELONGATION FACTORTS (Escherichiacoli) |
PF00009(GTP_EFTU)PF00889(EF_TS)PF03143(GTP_EFTU_D3)PF03144(GTP_EFTU_D2) | 4 | GLY A1316ASP A1314GLY A1353ILE A1310 | None | 0.65A | 5kr1B-3mmpA:undetectable | 5kr1B-3mmpA:10.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28ASP A 29ASP A 30VAL A 32GLY A 48 | None | 0.62A | 5kr1B-3mwsA:19.7 | 5kr1B-3mwsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32 | None | 0.47A | 5kr1B-3mwsA:19.7 | 5kr1B-3mwsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29VAL A 32GLY A 49ILE A 50 | None | 0.46A | 5kr1B-3mwsA:19.7 | 5kr1B-3mwsA:76.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oox | PUTATIVE 2OG-FE(II)OXYGENASE FAMILYPROTEIN (Caulobactervibrioides) |
PF03171(2OG-FeII_Oxy)PF14226(DIOX_N) | 4 | GLY A 88ALA A 89ASP A 90GLY A 188 | None | 0.57A | 5kr1B-3ooxA:undetectable | 5kr1B-3ooxA:16.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3opy | 6-PHOSPHOFRUCTO-1-KINASE ALPHA-SUBUNIT (Komagataellapastoris) |
PF00365(PFK) | 5 | GLY A 512ALA A 231VAL A 268GLY A 236ILE A 213 | None | 1.21A | 5kr1B-3opyA:undetectable | 5kr1B-3opyA:8.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r0z | D-SERINE DEHYDRATASE (Salmonellaenterica) |
PF00291(PALP) | 4 | ASN A 27GLY A 29ALA A 30GLY A 36 | None | 0.53A | 5kr1B-3r0zA:undetectable | 5kr1B-3r0zA:12.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rm5 | HYDROXYMETHYLPYRIMIDINE/PHOSPHOMETHYLPYRIMIDINE KINASE THI20 (Saccharomycescerevisiae) |
PF03070(TENA_THI-4)PF08543(Phos_pyr_kin) | 4 | GLY A 242VAL A 124GLY A 266ILE A 267 | SO4 A 1 (-3.3A)NoneNoneNone | 0.67A | 5kr1B-3rm5A:undetectable | 5kr1B-3rm5A:12.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s99 | BASIC MEMBRANELIPOPROTEIN (Brucellaabortus) |
PF02608(Bmp) | 4 | GLY A 134VAL A 245GLY A 160ILE A 161 | None | 0.65A | 5kr1B-3s99A:undetectable | 5kr1B-3s99A:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slz | GAG-PRO-POLPOLYPROTEIN (Murine leukemiavirus) |
PF00077(RVP) | 4 | GLY A 34ALA A 35VAL A 39GLY A 56 | 3TL A 126 (-3.1A)3TL A 126 ( 4.0A)None3TL A 126 (-3.4A) | 0.66A | 5kr1B-3slzA:11.1 | 5kr1B-3slzA:27.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32GLY A 49ILE A 50 | 017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-3.5A)017 A 201 (-4.2A)None017 A 201 (-4.0A)017 A 201 (-3.3A) | 0.22A | 5kr1B-3t3cA:18.8 | 5kr1B-3t3cA:73.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t44 | INDOLE-3-GLYCEROLPHOSPHATE SYNTHASE (Mycobacteriumtuberculosis) |
PF00218(IGPS) | 4 | GLY A 235ALA A 236ASP A 237ILE A 206 | None | 0.67A | 5kr1B-3t44A:undetectable | 5kr1B-3t44A:16.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tnx | PAPAIN (Carica papaya) |
PF00112(Peptidase_C1)PF08246(Inhibitor_I29) | 4 | ASN A 224GLY A 226ALA A 227GLY A 104 | None | 0.52A | 5kr1B-3tnxA:undetectable | 5kr1B-3tnxA:15.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3to4 | NKT VBETA2 (MOUSEVARIABLE DOMAIN,HUMAN CONSTANTDOMAIN) (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | GLY D 63ALA D 64ASP D 65GLY D 16 | None | 0.64A | 5kr1B-3to4D:undetectable | 5kr1B-3to4D:16.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30ILE A 50 | 017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)017 A 201 (-3.3A) | 0.47A | 5kr1B-3ttpA:19.3 | 5kr1B-3ttpA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29GLY A 49ILE A 50 | 017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-3.0A)017 A 201 (-3.3A) | 0.37A | 5kr1B-3ttpA:19.3 | 5kr1B-3ttpA:76.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u07 | UNCHARACTERIZEDPROTEIN VPA0106 (Vibrioparahaemolyticus) |
PF06742(DUF1214)PF06863(DUF1254) | 5 | ASN A 160GLY A 226ASP A 158ASP A 115VAL A 162 | None | 1.27A | 5kr1B-3u07A:undetectable | 5kr1B-3u07A:11.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u5t | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]REDUCTASE (Sinorhizobiummeliloti) |
PF13561(adh_short_C2) | 4 | GLY A 91ALA A 90GLY A 17ILE A 16 | None | 0.67A | 5kr1B-3u5tA:undetectable | 5kr1B-3u5tA:17.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50 | 017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 201 (-3.2A)017 A 201 ( 4.0A)017 A 202 (-2.9A)017 A 201 ( 3.5A) | 0.33A | 5kr1B-3u7sA:19.9 | 5kr1B-3u7sA:74.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3umm | PHOSPHORIBOSYLFORMYLGLYCINAMIDINESYNTHASE (Salmonellaenterica) |
PF02769(AIRS_C)PF13507(GATase_5) | 4 | GLY A 504ALA A 505GLY A 447ILE A 446 | ANP A2001 ( 3.9A)NoneNoneNone | 0.58A | 5kr1B-3ummA:undetectable | 5kr1B-3ummA:5.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wfz | LACTO-N-BIOSEPHOSPHORYLASE (Bifidobacteriumlongum) |
PF09508(Lact_bio_phlase)PF17385(LBP_M)PF17386(LBP_C) | 4 | GLY A 27ALA A 28ASP A 29GLY A 398 | None | 0.66A | 5kr1B-3wfzA:undetectable | 5kr1B-3wfzA:8.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wj2 | CARBOXYLESTERASE (Ferroplasmaacidiphilum) |
PF07859(Abhydrolase_3) | 5 | GLY A 282ASP A 251VAL A 7GLY A 276ILE A 296 | None | 1.27A | 5kr1B-3wj2A:undetectable | 5kr1B-3wj2A:15.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zyy | IRON-SULFUR CLUSTERBINDING PROTEIN (Carboxydothermushydrogenoformans) |
PF00111(Fer2)PF14574(DUF4445) | 4 | GLY X 577ALA X 578GLY X 355ILE X 357 | None | 0.62A | 5kr1B-3zyyX:undetectable | 5kr1B-3zyyX:11.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bj4 | AMPDH2 (Pseudomonasaeruginosa) |
PF01471(PG_binding_1)PF01510(Amidase_2) | 4 | GLY A 230ALA A 231ASP A 155GLY A 165 | None | 0.59A | 5kr1B-4bj4A:undetectable | 5kr1B-4bj4A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c1n | IRON-SULFUR CLUSTERBINDING PROTEIN (Carboxydothermushydrogenoformans) |
PF14574(DUF4445) | 4 | GLY I 577ALA I 578GLY I 355ILE I 357 | None | 0.67A | 5kr1B-4c1nI:undetectable | 5kr1B-4c1nI:13.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cuo | BANYAN PEROXIDASE (Ficusbenghalensis) |
PF00141(peroxidase) | 5 | GLY A 51ALA A 98ASP A 99GLY A 283ILE A 285 | NoneNoneNone CL A1331 ( 4.7A)CO3 A1336 ( 4.9A) | 1.32A | 5kr1B-4cuoA:undetectable | 5kr1B-4cuoA:14.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dy5 | GIFSY-1 PROPHAGEPROTEIN (Salmonellaenterica) |
PF04151(PPC) | 4 | ASN A 68GLY A 70ALA A 71ASP A 72 | NoneNoneNoneGOL A 202 (-3.1A) | 0.60A | 5kr1B-4dy5A:undetectable | 5kr1B-4dy5A:19.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e4y | SHORT CHAINDEHYDROGENASE FAMILYPROTEIN (Francisellatularensis) |
PF13561(adh_short_C2) | 4 | GLY A 76ALA A 75GLY A 14ILE A 13 | None | 0.62A | 5kr1B-4e4yA:undetectable | 5kr1B-4e4yA:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eut | SERINE/THREONINE-PROTEIN KINASE TBK1 (Homo sapiens) |
PF00069(Pkinase) | 4 | GLY A 199ALA A 200ASP A 203GLY A 130 | None | 0.57A | 5kr1B-4eutA:undetectable | 5kr1B-4eutA:14.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fn5 | ELONGATION FACTOR G1 (Pseudomonasaeruginosa) |
PF00009(GTP_EFTU)PF00679(EFG_C)PF03144(GTP_EFTU_D2)PF03764(EFG_IV)PF14492(EFG_II) | 4 | GLY A 571ALA A 570VAL A 698GLY A 613 | None | 0.64A | 5kr1B-4fn5A:undetectable | 5kr1B-4fn5A:9.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g9s | INHIBITOR OF G-TYPELYSOZYME (Escherichiacoli) |
PF04151(PPC) | 4 | ASN B 68GLY B 70ALA B 71ASP B 72 | None | 0.56A | 5kr1B-4g9sB:undetectable | 5kr1B-4g9sB:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hcy | THIAMINASE-I (Naegleriagruberi) |
no annotation | 4 | GLY A 296ASP A 293GLY A 307ILE A 308 | None | 0.66A | 5kr1B-4hcyA:undetectable | 5kr1B-4hcyA:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jyj | ENOYL-COAHYDRATASE/ISOMERASE (Novosphingobiumaromaticivorans) |
PF00378(ECH_1) | 4 | ALA A 120ASP A 121GLY A 54ILE A 19 | None | 0.63A | 5kr1B-4jyjA:undetectable | 5kr1B-4jyjA:17.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28ASP A 29ASP A 30VAL A 32GLY A 48 | RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)NoneRIT A 500 (-4.8A) | 0.63A | 5kr1B-4njvA:20.2 | 5kr1B-4njvA:83.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32 | RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)None | 0.46A | 5kr1B-4njvA:20.2 | 5kr1B-4njvA:83.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29VAL A 32GLY A 49ILE A 50 | RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)NoneRIT A 500 (-3.4A)RIT A 500 (-4.3A) | 0.54A | 5kr1B-4njvA:20.2 | 5kr1B-4njvA:83.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o5h | PHENYLACETALDEHYDEDEHYDROGENASE (Burkholderiacenocepacia) |
PF00171(Aldedh) | 5 | ASP A 291ASP A 289VAL A 288GLY A 324ILE A 326 | None | 1.16A | 5kr1B-4o5hA:undetectable | 5kr1B-4o5hA:13.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ofq | PUTATIVE CELLSURFACE PROTEIN (Streptococcuspyogenes) |
PF16364(Antigen_C) | 4 | GLY A1269ALA A1270ASP A1271GLY A1232 | None | 0.64A | 5kr1B-4ofqA:undetectable | 5kr1B-4ofqA:15.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ony | EXTRACELLULARSOLUTE-BINDINGPROTEIN FAMILY 5 (Brucellamelitensis) |
PF00496(SBP_bac_5) | 4 | GLY A 381ALA A 382VAL A 524GLY A 554 | None | 0.67A | 5kr1B-4onyA:undetectable | 5kr1B-4onyA:11.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ra7 | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Atopobiumparvulum) |
PF00905(Transpeptidase) | 4 | GLY A 933ALA A 934GLY A 907ILE A 906 | None | 0.55A | 5kr1B-4ra7A:undetectable | 5kr1B-4ra7A:12.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ttp | DEPHOSPHO-COA KINASE (Legionellapneumophila) |
PF01121(CoaE) | 5 | ALA A 175ASP A 176ASP A 177GLY A 12ILE A 118 | None | 0.86A | 5kr1B-4ttpA:undetectable | 5kr1B-4ttpA:18.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u1r | ATP-DEPENDENT6-PHOSPHOFRUCTOKINASE, PLATELET TYPE (Homo sapiens) |
PF00365(PFK) | 5 | GLY A 326ALA A 45VAL A 82GLY A 50ILE A 27 | None | 1.31A | 5kr1B-4u1rA:undetectable | 5kr1B-4u1rA:9.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uqz | HSIB1HSIE1 (Pseudomonasaeruginosa) |
PF05591(T6SS_VipA)PF07024(ImpE) | 4 | ASN A 57ASP A 88VAL A 84GLY B 29 | None | 0.65A | 5kr1B-4uqzA:undetectable | 5kr1B-4uqzA:15.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yah | D-METHIONINE-BINDINGLIPOPROTEIN METQ (Escherichiacoli) |
PF03180(Lipoprotein_9) | 4 | GLY X 40ALA X 41GLY X 210ILE X 209 | None | 0.60A | 5kr1B-4yahX:undetectable | 5kr1B-4yahX:17.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 4 | GLY A 34ALA A 35ASP A 36GLY A 58 | 4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)4B1 A 201 (-3.4A) | 0.53A | 5kr1B-4ydfA:12.5 | 5kr1B-4ydfA:32.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 4 | GLY A 34ALA A 35ASP A 36VAL A 39 | 4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)None | 0.39A | 5kr1B-4ydfA:12.5 | 5kr1B-4ydfA:32.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z0t | OXIDOREDUCTASE,SHORT-CHAINDEHYDROGENASE/REDUCTASE FAMILY (Brucella ovis) |
PF00106(adh_short) | 4 | GLY A 93ALA A 92GLY A 20ILE A 19 | None BR A 305 (-3.6A)None BR A 304 (-4.5A) | 0.64A | 5kr1B-4z0tA:undetectable | 5kr1B-4z0tA:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z1p | CELL WALL SURFACEANCHOR PROTEIN (Streptococcusagalactiae) |
PF16364(Antigen_C) | 4 | GLY A 291ALA A 292ASP A 293GLY A 254 | None | 0.67A | 5kr1B-4z1pA:undetectable | 5kr1B-4z1pA:13.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z23 | CELL WALL SURFACEANCHOR PROTEIN (Streptococcusagalactiae) |
PF16364(Antigen_C) | 4 | GLY A 291ALA A 292ASP A 293GLY A 254 | None | 0.66A | 5kr1B-4z23A:undetectable | 5kr1B-4z23A:16.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z8x | ATP-DEPENDENT ZINCMETALLOPROTEASE FTSH (Aquifexaeolicus) |
PF00004(AAA)PF01434(Peptidase_M41) | 4 | GLY A 492ALA A 493ASP A 496ILE A 417 | NoneNone ZN A 701 (-2.2A)None | 0.63A | 5kr1B-4z8xA:undetectable | 5kr1B-4z8xA:12.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASN A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49 | None | 0.56A | 5kr1B-5b18A:18.5 | 5kr1B-5b18A:71.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b7n | MTA/SAH NUCLEOSIDASE (Aeromonashydrophila) |
PF01048(PNP_UDP_1) | 4 | ASN A 125GLY A 127ALA A 128VAL A 150 | None | 0.42A | 5kr1B-5b7nA:undetectable | 5kr1B-5b7nA:17.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5bqn | BOTULINUM NEUROTOXINTYPE D,BOTULINUMNEUROTOXIN TYPE D (Clostridiumbotulinum) |
PF01742(Peptidase_M27)PF07952(Toxin_trans) | 5 | GLY A 668ASP A 548VAL A 547GLY A 645ILE A 644 | None | 1.49A | 5kr1B-5bqnA:undetectable | 5kr1B-5bqnA:8.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cej | 3-OXOACYL-[ACYL-CARRIER PROTEIN]REDUCTASE (Yersinia pestis) |
PF13561(adh_short_C2) | 4 | GLY A 88ALA A 87GLY A 18ILE A 17 | None | 0.65A | 5kr1B-5cejA:undetectable | 5kr1B-5cejA:19.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5esc | HUPZ (Streptococcussp. 'group A') |
PF01243(Putative_PNPOx) | 4 | GLY A 60VAL A 17GLY A 108ILE A 109 | None | 0.56A | 5kr1B-5escA:undetectable | 5kr1B-5escA:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ez7 | FLAVOENZYME PA4991 (Pseudomonasaeruginosa) |
PF01266(DAO) | 4 | ASN A 209GLY A 206ALA A 205GLY A 18 | NoneFAD A 401 (-3.8A)FAD A 401 (-3.7A)None | 0.65A | 5kr1B-5ez7A:undetectable | 5kr1B-5ez7A:16.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fir | 5'-3'EXORIBONUCLEASE 2HOMOLOG (Caenorhabditiselegans) |
PF03159(XRN_N) | 4 | GLY A 232ASP A 234ASP A 236GLY A 205 | None | 0.63A | 5kr1B-5firA:undetectable | 5kr1B-5firA:10.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fok | IRON TRANSPORT OUTERMEMBRANE RECEPTOR (Pseudomonasaeruginosa) |
PF00593(TonB_dep_Rec)PF07715(Plug) | 4 | GLY A 217ASP A 219GLY A 181ILE A 180 | None | 0.66A | 5kr1B-5fokA:undetectable | 5kr1B-5fokA:8.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5g56 | CARBOHYDRATE BINDINGFAMILY 6 (Ruminiclostridiumthermocellum) |
PF00150(Cellulase)PF03422(CBM_6) | 5 | GLY A 372ALA A 363VAL A 437GLY A 566ILE A 516 | None | 1.12A | 5kr1B-5g56A:undetectable | 5kr1B-5g56A:8.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gw7 | GLUCOSIDASE YGJK (Escherichiacoli) |
PF01204(Trehalase) | 4 | GLY A 626ASP A 605GLY A 507ILE A 509 | None | 0.66A | 5kr1B-5gw7A:undetectable | 5kr1B-5gw7A:9.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i5l | BACTERIOPHYTOCHROMEPROTEIN (Agrobacteriumfabrum) |
PF00360(PHY)PF01590(GAF)PF08446(PAS_2) | 4 | GLY A 357ALA A 358ASP A 359GLY A 418 | None | 0.58A | 5kr1B-5i5lA:undetectable | 5kr1B-5i5lA:12.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j6f | 3-DEOXY-D-ARABINO-HEPTULOSONATE7-PHOSPHATESYNTHASE, CHORISMATEMUTASE-ISOZYME 3 (Geobacillus sp.GHH01) |
PF00793(DAHP_synth_1)PF01817(CM_2) | 4 | GLY A 315ALA A 316ASP A 317ILE A 281 | None | 0.61A | 5kr1B-5j6fA:undetectable | 5kr1B-5j6fA:15.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j8j | HISTONE DEACETYLASEHDA1 (Saccharomycescerevisiae) |
PF09757(Arb2) | 4 | GLY A 679ASP A 624GLY A 596ILE A 595 | None | 0.64A | 5kr1B-5j8jA:undetectable | 5kr1B-5j8jA:18.33 |